Results 1 to 10 of about 6,709,602 (308)

Primary and Secondary Negative Symptoms in Schizophrenia

open access: yesFrontiers in Psychiatry, 2022
The negative symptoms of schizophrenia include volitional (motivational) impairment manifesting as avolition, anhedonia, social withdrawal, and emotional disorders such as alogia and affective flattening.
Sergey N. Mosolov   +2 more
doaj   +3 more sources

Effectiveness of spironolactone on schizophrenia symptoms: A double-blind randomized clinical trial [PDF]

open access: yesروانشناسی و روانپزشکی شناخت, 2023
Introduction: Schizophrenia is a mental disorder in which the facts surrounding a person are interpreted as abnormal. The treatment aims to reduce symptoms and the possibility of disease recurrence. Aim: This study aimed to investigate the effectiveness
Nazanin Hoghoughi   +4 more
doaj   +1 more source

EPA guidance on assessment of negative symptoms in schizophrenia

open access: yesEuropean Psychiatry, 2021
BackgroundDuring the last decades, a renewed interest for negative symptoms (NS) was brought about by the increased awareness that they interfere severely with real-life functioning, particularly when they are primary and persistent.MethodsIn this ...
S. Galderisi   +13 more
doaj   +1 more source

Apathy in schizophrenia: assessment in clinical settings and overlap with other dimensions of impairment

open access: yesEuropean Psychiatry, 2021
Negative symptoms are considered a core feature of schizophrenia. They are present since the prodromal phase and tend to persist more than other psychopathological dimensions in the chronic stages.
A. Mucci   +4 more
doaj   +1 more source

Negative and Cognitive Symptoms of Schizophrenia: Are there Adequate Pharmacological Treatments?

open access: yesEuropean Psychiatry, 2022
Introduction The ongoing debate regarding the treatment efficacy for negative and cognitive symptoms in schizophrenia is a subject of continuous frustration among psychiatrists.
O. Vasiliu
doaj   +1 more source

Adjunctive simvastatin treatment in schizophrenia patients; a double blind randomized and placebo controlled trial [PDF]

open access: yesJournal of Preventive Epidemiology, 2022
Introduction: Statins such as simvastatin are recently introduced as agents that may have beneficial effects in schizophrenia regarding their prominent anti-inflammatory properties.
Somaieh Ashrafi   +6 more
doaj   +1 more source

Management of cognitive and negative symptoms in schizophrenia [PDF]

open access: yesMental Health Clinician, 2022
Currently available antipsychotics provide only modest benefit in managing the cognitive and negative symptoms of schizophrenia even though these symptoms are often the most impairing in patients daily lives.
Megan Maroney, PharmD, BCPP
doaj   +1 more source

Negative symptoms - a real unmet need

open access: yesEuropean Psychiatry, 2022
Introduction Schizophrenia is frequently a chronic and disabling disorder, characterized by heterogeneous positive and negative symptoms. Negative symptoms are a major health concern and a core component of schizophrenia that account for a large part of
I. Soares Da Costa, R. Moreira
doaj   +1 more source

Association of Negative Symptoms of Schizophrenia Assessed by the BNSS and SNS Scales With Neuropsychological Performance: A Gender Effect

open access: yesFrontiers in Psychiatry, 2021
Objective: The relationship between negative symptoms and neurocognitive performance in schizophrenia is well documented, but the mechanism of these connections remains unclear.
Paweł Wójciak   +4 more
doaj   +1 more source

Relationship between Disability and Psychopathology Severity in Subjects having Acute Exacerbation of Schizophrenia on Treatment over three Month’s Duration [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2018
Introduction: Schizophrenia is a disorder which has a chronic course frequently with subjects having significant disability. Understanding what the symptoms during initial period are, which predict level of disability in future would be useful.
Praveen Arathil   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy